Cyclooxygenase-2 inhibitors and other NSAIDs in urology: current peril or future promise?
Pruthi
Raj S
RS
Division of Urologic Surgery, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA. rpruthi@med.unc.edu
Kouba
Erik
E
Carson
Culley C
CC
Wallen
Eric M
EM
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000139:chemically induced; D051546:Cyclooxygenase 2 / Q000502:physiology; D052246:Cyclooxygenase 2 Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D005544:Forecasting; D006801:Humans; D014570:Urologic Diseases / Q000188:drug therapy* / Q000209:etiology
D000894:Anti-Inflammatory Agents, Non-Steroidal; D052246:Cyclooxygenase 2 Inhibitors; D051546:Cyclooxygenase 2